Last updated: 2026-09-16 13:20:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Dogwood Therapeutics, Inc. (DWTX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1,82, with a market capitalisation of $62,72M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1,28 to $9,50. This page covers its latest market performance, valuation, price trends and company information.
$62,72M | |
$1,73 | |
$29,28 | |
$1,28 | |
$1,73 | |
11,61K | |
77,62K | |
-- | |
$9,50 | |
$1,28 | |
-- | |
-- |
Dogwood Therapeutics, Inc. (DWTX) is trading at $1,82 in pre-market trading as of 2026-09-16 12:56:00, up 4,91% ($0,08) from the previous close of $1,73
Pre-market trading shows how investors are pricing DWTX before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, Dogwood Therapeutics, Inc. (DWTX) moved from $2,29 to $1,82, representing a decline of 20,74% ($0,48).
The stock traded between $1,72 and $2,38 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 63,26 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 6,5%
DWTX is currently trading at $1,82, placing it 6,5% of the way from its 52-week low of $1,28 to its 52-week high of $9,50. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Dogwood Therapeutics Inc is a development-stage biopharmaceutical company focused on developing new medicines to treat pain and neuropathy. The pipeline is focused on treating chronic neuropathic pain and neuropathy. The Company operates in one segment and is a pre-revenue, development-stage biopharmaceutical company focused on developing new medicines to treat pain and peripheral neuropathy associated with cancer.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 8 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Dogwood Therapeutics, Inc. (DWTX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.